 |
Market Research Report
Liquid Biopsy |
||||||
| Published by | Global Industry Analysts, Inc. | Product code | 908033 | ||||
| Published | Content info | 148 Pages Delivery time: 1-2 business days |
|||||
| Price |
|
||||||
| Liquid Biopsy | ||
| Published: September 1, 2020 | Content info: 148 Pages |
|
Global Liquid Biopsy Market to Reach $3.8 Billion by 2027
Amid the COVID-19 crisis, the global market for Liquid Biopsy estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$3.8 Billion by 2027, growing at a CAGR of 20.2% over the analysis period 2020-2027. Lung, one of the segments analyzed in the report, is projected to record a 20.5% CAGR and reach US$1.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Breast segment is readjusted to a revised 21.5% CAGR for the next 7-year period.
The U.S. Market is Estimated at $315 Million, While China is Forecast to Grow at 19.8% CAGR
The Liquid Biopsy market in the U.S. is estimated at US$315 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$672.3 Million by the year 2027 trailing a CAGR of 19.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18.1% and 17.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 14.1% CAGR.
Colorectal Segment to Record 19.5% CAGR
In the global Colorectal segment, USA, Canada, Japan, China and Europe will drive the 19.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$144.5 Million in the year 2020 will reach a projected size of US$502.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$447.7 Million by the year 2027.We bring years of research experience to this 9th edition of our report. The 148-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others,
Global Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, & Others), Initiatives, Funding, Major Deals, 35 Company Profiles & Recent Developments-Forecast to 2027
Europe Liquid Biopsy Market to 2027-Regional Analysis & Forecasts by Product & Services ; Sample ; Circulating Biomarker ; Application ; End User ; & Country-Regional Analysis & Market Forecasts
North America Liquid Biopsy Market to 2027 - Regional Analysis & Forecasts by Product & Services ; Sample ; Circulating Biomarker ; Application ; End User ; & Country - Regional Analysis & Market Forecasts
Global Liquid Biopsy Market Forecast 2020-2028
Liquid Biopsy Market Report 2020-2030: Forecasts by Product (Instruments, Kits & Reagents, Services), Sample Type (Blood Samples, Urine Samples, Others), Biomarker, Cancer Type, End-user, Region, plus Analysis of Leading Companies
Liquid Biopsy Markets by Cancer Type and by Usage Type with Impact of Covid-19 Pandemic. Including Executive and Consultant Guides and Customized Forecasting and Analysis 2020-2024
Liquid Biopsy Market, by Sample Type, By Technology (Multi-gene-parallel Analysis, and Single Gene Analysis ), By Biomaker, By Application, By Technology, and By Geography - Analysis, Share, Trends, Size, & Forecast From 2020 - 2026
Liquid Biopsy Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product and Services; Sample; Circulating Biomarker; Application; End User, and Geography
Liquid Biopsy Market Global Report 2020-30
Liquid Biopsy | Medtech 360 | Market Insights | United States
